Sands Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.39M | Buy |
|
|||||
|
2024
Q4 | $1.34M | Sell |
|
|||||
|
2024
Q3 | $352M | Sell |
|
|||||
|
2024
Q2 | $522M | Sell |
|
|||||
|
2024
Q1 | $554M | Sell |
|
|||||
|
2023
Q4 | $465M | Buy |
|
|||||
|
2023
Q3 | $314M | Sell |
|
|||||
|
2023
Q2 | $440M | Sell |
|
|||||
|
2023
Q1 | $514M | Sell |
|
|||||
|
2022
Q4 | $561M | Sell |
|
|||||
|
2022
Q3 | $860M | Sell |
|
|||||
|
2022
Q2 | $1.11B | Buy |
|
|||||
|
2022
Q1 | $1.38B | Sell |
|
|||||
|
2021
Q4 | $1.65B | Sell |
|
|||||
|
2021
Q3 | $1.53B | Buy |
|
|||||
|
2021
Q2 | $1.39B | Buy |
|
|||||
|
2021
Q1 | $1.09B | Buy |
|
|||||
|
2020
Q4 | $1.06B | Sell |
|
|||||
|
2020
Q3 | $963M | Sell |
|
|||||
|
2020
Q2 | $859M | Sell |
|
|||||
|
2020
Q1 | $832M | Sell |
|
|||||
|
2019
Q4 | $1.42B | Sell |
|
|||||
|
2019
Q3 | $1.63B | Sell |
|
|||||
|
2019
Q2 | $1.39B | Sell |
|
|||||
|
2019
Q1 | $1.47B | Sell |
|
|||||
|
2018
Q4 | $1.22B | Sell |
|
|||||
|
2018
Q3 | $1.46B | Buy |
|
|||||
|
2018
Q2 | $1.01B | Buy |
|
|||||
|
2018
Q1 | $910M | Sell |
|
|||||
|
2017
Q4 | $784M | Sell |
|
|||||
|
2017
Q3 | $791M | Sell |
|
|||||
|
2017
Q2 | $903M | Sell |
|
|||||
|
2017
Q1 | $753M | Sell |
|
|||||
|
2016
Q4 | $780M | Sell |
|
|||||
|
2016
Q3 | $1.09B | Sell |
|
|||||
|
2016
Q2 | $959M | Sell |
|
|||||
|
2016
Q1 | $897M | Sell |
|
|||||
|
2015
Q4 | $863M | Buy |
|
|||||
|
2015
Q3 | $188M | Buy |
|